Alkem Laboratories Limited has submitted a regulatory disclosure to both National Stock Exchange of India Limited and BSE Limited regarding an upcoming board meeting.
The notice is provided under Regulation 29 read with Regulation 33 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.
A meeting of the Board of Directors of the Company is scheduled to be held on Friday, 14th August, 2026. The primary agenda includes considering and approving both the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter ended 30th June, 2026.